Found 14 matching trials
Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant Immunochemotherapy
PHASE3This is a Phase III, multicenter, open-label, randomized controlled trial. ...
Location
Henan Cancer Hospital
Trial on Delay Phenomenon Utility in Preventing Anastomotic Leakage After an Esophagectomy
NAThis is a randomized clinical trial to clarify if the delay phenomenon coul...
Location
Leandre Farran Teixidor
Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma
PHASE2China with high incidence of esophageal cancer, the number of new cases and...
Status
Active Not Recruiting
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Neoadjuvant Ivonescimab(AK112) Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma
PHASE2In the past few decades, surgery, radiotherapy, chemotherapy and other trea...
Location
The Second Affiliated Hospital of Zhejiang University
Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)
PHASE3The primary objective is to compare docetaxel plus cisplatin (DP) versus vi...
Location
Sun Yat-sen University Cancer Center
CHFR Methylation Status Esophageal Cancer Study
PHASE2This is a Phase 2 Study of Paclitaxel with Cisplatin versus Fluoropyrimidin...
Location
Ronan Kelly, M.D.
PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101)
PHASE3The primary objective is to compare PD-1 inhibitor combined with preoperati...
Location
Sun Yat-sen University Cancer Center
Robot-assisted Thoracic Approach Versus Open Transthoracic Esophagectomy .
NAThis is a randomized controlled trial designed to compare robot-assisted th...
Location
Hospital Universitari de Bellvitge
Cancer of Esophagogastric Junction: Optimized Sweet Versus Ivor-Lewis
NAThis study is being done to see whether Optimized Sweet Procedure is superi...
Location
Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School
Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell Carcinoma
PHASE2In the management of locally advanced esophageal squamous cell carcinoma, t...
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University